Insufficient scRNA-seq data for expression of NFE4 at single-cell level.
Insufficient scRNA-seq data for expression of NFE4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 268.88 | 258 / 258 | 40% | 7.62 | 91 / 230 |
lung | 81% | 27.38 | 467 / 578 | 20% | 4.52 | 227 / 1155 |
spleen | 98% | 131.39 | 235 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 502.87 | 755 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 81% | 22.09 | 1079 / 1335 | 0% | 0 | 0 / 0 |
ovary | 79% | 15.09 | 142 / 180 | 0% | 0.01 | 1 / 430 |
breast | 55% | 8.01 | 252 / 459 | 8% | 5.67 | 85 / 1118 |
adipose | 57% | 10.78 | 688 / 1204 | 0% | 0 | 0 / 0 |
prostate | 42% | 5.67 | 104 / 245 | 1% | 0.01 | 3 / 502 |
thymus | 40% | 4.70 | 263 / 653 | 1% | 0.05 | 8 / 605 |
uterus | 28% | 3.46 | 47 / 170 | 10% | 2.68 | 47 / 459 |
pancreas | 13% | 1.46 | 44 / 328 | 23% | 2.42 | 41 / 178 |
bladder | 29% | 10.00 | 6 / 21 | 8% | 1.10 | 39 / 504 |
liver | 24% | 3.55 | 54 / 226 | 3% | 0.65 | 11 / 406 |
stomach | 21% | 3.03 | 74 / 359 | 5% | 0.28 | 14 / 286 |
esophagus | 14% | 1.76 | 197 / 1445 | 9% | 1.41 | 17 / 183 |
heart | 23% | 2.86 | 194 / 861 | 0% | 0 | 0 / 0 |
kidney | 12% | 1.27 | 11 / 89 | 4% | 1.07 | 40 / 901 |
intestine | 10% | 1.22 | 101 / 966 | 5% | 0.26 | 26 / 527 |
skin | 11% | 1.11 | 204 / 1809 | 4% | 0.52 | 19 / 472 |
lymph node | 0% | 0 | 0 / 0 | 10% | 5.96 | 3 / 29 |
brain | 7% | 0.71 | 175 / 2642 | 3% | 0.08 | 21 / 705 |
muscle | 5% | 0.57 | 41 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 1.12 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005634 | Cellular component | nucleus |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NFE4 |
Protein name | Transcription factor NF-E4 |
Synonyms | |
Description | FUNCTION: Functions as part of the SSP (stage selector protein) complex, a complex that contributes to the preferential expression of the gamma-gene in fetal erythroid cells by facilitating the interaction of the gamma-globin genes with enhancer elements contained in the locus control region (LCR). The complex binds to the stage selector element (SSE) in the proximal gamma-globin promoter. In contrast, isoform 2 acts as a repressor of gamma-globin gene expression by preventing NFE2 and RNA polymerase II recruitment to the promoter. . |
Accessions | Q86UQ8 |